ISS Says Puma Biotechnology Is In A 'Critical Stage' Of Turnaround Plan, Urges Investors To Vote Against Proposal By Fred Eshelman
December 23, 2015 at 10:45 AM EST
Dr. Fred Eshelman is the founder of Eshelman Ventures, an investment firm that focuses on healthcare companies. The investment firm ...
